The 2025-2030 World Outlook for Alzheimer's Treatments - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Alzheimer's Treatments

Subjects

Out of stock

Price data last checked 13 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 266 days. Could come back at any time — we're watching for you.

Out of stock 266 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 391 days · 391 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 391 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (391 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 391 days

Description

This study covers the world outlook for Alzheimer's treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of Alzheimer's treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Allergan, Daiichi Sankyo Company, Eisai Company, Eli Lilly and Company, H. Lundbeck, Janssen, NeuroEM Therapeutics, Inc., and Neuronix. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0D156ZT63
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 10 May 2024

The 2025-2030 World Outlook for Alzheimer's Treatments

Gone for 266 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 World Outlook for Alzheimer's Treatments

The 2023-2028 Outlook for Alzheimer's Treatments in China

The 2023-2028 Outlook for Alzheimer's Treatments in Japan

The 2023 Report on Alzheimer's Treatments: World Market Segmentation by City

The 2023-2028 Outlook for Alzheimer's Treatments in India

Clinical Advances in Alzheimer's Disease

Alzheimer's Disease: A Practical Guide

AI-Driven Alzheimer's Disease Detection and Prediction

Alzheimer’s Disease: Diagnosis, Molecular Targets, and Therapeutic Modalities

Academic Press - Differentiating Factors in Alzheimer's Disease

Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease: Non-Pharmacological Therapies for Alzheimer's Disease

Causes, Diagnosis and Treatment of Alzheimer's Disease - Book

Alzheimer's Disease: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities

Handbook of Alzheimer's Disease

Alzheimer's Disease: Pathological and Clinical Findings: 3 (Recent Advances in Alzheimer Research)

Pathobiology of Alzheimer's Disease

Alzheimer's Disease: Diagnostic and Therapeutic Strategies

Redirecting Alzheimer Strategy: Tracing Memory Loss to Self Pathology

Handbuch Alzheimer-Krankheit: Grundlagen – Diagnostik – Therapie – Versorgung – Prävention

Molecular Research of Alzheimer's Disease

Alternative opportunities for Alzheimer's disease: Hormones away from Alzheimer's disease

Alzheimer's Disease: Past, Present and Future

Non-neuronal Cells in Alzheimer's Disease

Pharmacological Treatment of Alzheimer's Disease: Scientific and Clinical Aspects